Detalhe da pesquisa
1.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med
; 386(5): 437-448, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045221
2.
Survival with Cemiplimab in Recurrent Cervical Cancer.
N Engl J Med
; 386(6): 544-555, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139273
3.
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer.
Int J Cancer
; 154(9): 1607-1615, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196128
4.
Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan.
Hepatol Res
; 54(1): 4-23, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906585
5.
Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection.
Hepatol Res
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874115
6.
Analysis of autoimmune hepatitis with acute presentation in the early stage of illness.
J Gastroenterol Hepatol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860418
7.
Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors.
Int J Gynecol Cancer
; 34(4): 586-593, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989482
8.
The International Gynecologic Cancer Society consensus statement on palliative care.
Int J Gynecol Cancer
; 2024 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38909991
9.
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
Int J Clin Oncol
; 29(4): 407-416, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430303
10.
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.
Int J Clin Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767719
11.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Gynecol Oncol
; 170: 300-308, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758420
12.
Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center.
Hepatol Res
; 53(4): 357-369, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541110
13.
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
Int J Clin Oncol
; 28(3): 454-467, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648710
14.
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study.
Int J Clin Oncol
; 28(6): 804-815, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140771
15.
Development of a Japanese Scale that Evaluates the Level of Nursing Support Provided to Patients for Decision-Making in Cancer Clinical Trials.
J Cancer Educ
; 38(5): 1548-1556, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024607
16.
[Gynecologic Oncology Global Clinical Trial Initiatives, since 1997].
Gan To Kagaku Ryoho
; 50(1): 35-38, 2023 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-36759983
17.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901833
18.
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
Cancer Sci
; 113(8): 2788-2797, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633184
19.
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775.
Cancer Sci
; 113(10): 3489-3497, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612971
20.
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Cancer Sci
; 113(11): 3877-3887, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792064